Endless dilemma over the big C

There is a lot more that needs to be done to improve outcomes of rare cancers. Diagnostic accuracy, better treatment and prognosis are the need of the hour

The Indian healthcare system has markedly improved in the last few years. However, one of the areas where it lacks is judicious treatment of rare cancers. The problem with this disease is multi-faceted and has many aspects to it. The conundrum in India begins with the lack of a correct definition for it. Then comes other issues such as difficulty in diagnosis, absence of registries, dearth of experts and the lack of data and newer drugs, approved as orphan drug elsewhere. All of these factors lead to poor outcomes. This disease may be rare individually, but collectively, the varied manifestations constitute almost 20 per cent of all cancers. Thus, they cannot be ignored. Read More

Leave a Reply

Your email address will not be published. Required fields are marked *